Annexon, Inc.
- ANNX
- NASDAQ
- Biotechnology
- Complement Inhibitors (C1q)
- Autoimmune Therapies
- Neurodegenerative Therapies
$3.41
Today −5.28%Quote Oct 16, 2026, 08:00 PM UTC
−18.23%over the last month
Max drawdown −19.4%From 1-month high −19.4%3 months −38.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$685.4M
Approximate share count
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$10.50
+207.9% from here
Floor
$3.37
1.3% below price
Where the price sits
11 analysts
Analyst range, low to high
$7.00$14.00
- Price $3.41
- Resistance $3.61
- Consensus $10.50
The price is just above its floor. Analysts' average target sits about 208% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ANNXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
92